This proposed legislation, titled the "LABEL Act," seeks to amend the Federal Food, Drug, and Cosmetic Act by establishing new labeling requirements for abortion-inducing drugs. Under this bill, such drugs would be considered misbranded unless their labels clearly identify both the name and address of the dispenser and the name of the prescriber . The bill defines an "abortion-inducing drug" as one intended or used to kill an unborn child or terminate a pregnancy, specifically excluding drugs used for removing a dead unborn child or treating an ectopic pregnancy. Furthermore, it prohibits states from implementing or enforcing labeling requirements that are less stringent than these federal standards, aiming to ensure a uniform approach to tracking these medications.